Table 3.
Number of Medicare prescriptions dispensed for each antihypertensive fixed-dose combination product in the United States in 2018.
| Antihypertensive medication class combination | Generic name Brand name |
Generic dispenses | Brand dispenses |
|---|---|---|---|
| ACEI/thiazide diuretic | |||
| Moexipril/HCTZ Uniretic® |
10,290 | 0 | |
| ARB/thiazide diuretic | |||
| Azilsartan/chlorthalidone Edarbyclor |
0 | 67,752 | |
| ACEI/CCB | |||
| Perindopril/amlodipine Prestalia |
0 | 14 | |
| ARB/CCB | |||
| Telmisartan/amlodipine Twynsta® |
686,682 | 279 | |
| ARB/CCB/thiazide diuretic | |||
| Valsartan/amlodipine/ HCTZ Exforge HCT® |
87,652 | 2,499 | |
| Beta-blocker/thiazide diuretic | |||
| Metoprolol succinate/HCTZ Dutoprol® |
0 | 1,237 | |
| Potassium-sparing diuretic/thiazide diuretic | |||
| Amiloride/HCTZ (none) |
71,435 | 0 | |
| Aldosterone antagonist/thiazide diuretic | Spironolactone/HCTZ Aldactazide® |
265,366 | 1,064 |
| Alpha-2-agonist/thiazide diuretic | Methyldopa/HCTZ (none) |
812 | 0 |
| Direct renin inhibitor/thiazide diuretic | Aliskiren/HCTZ Tekturna HCT |
0 | 13,210 |
ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel antagonist; HCTZ: hydrochlorothiazide; rx: prescription
Utilization data were generated from the 2014–2018 Medicare Part D Drug Spending Data available from the Centers for Medicaid and Medicare Services (https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Information-on-Prescription-Drugs/MedicarePartD).